Intuitive Surgical, Inc. $ISRG is Exome Asset Management LLC's 10th Largest Position

Key Points

• Exome Asset Management LLC reduced its stake in Intuitive Surgical by 14.4%, leaving it with 6,358 shares worth approximately $3.15 million.
• Intuitive Surgical reported a 28.51% net margin and 21.4% revenue growth, with quarterly earnings per share at $2.19, exceeding estimates.
• Insider trading activity included an EVP selling 4,500 shares, representing a 92.73% decrease in their position, while corporate insiders own only 0.70% of the company.

Exome Asset Management LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,358 shares of the medical equipment provider's stock after selling 1,069 shares during the quarter. Intuitive Surgical accounts for approximately 2.7% of Exome Asset Management LLC's investment portfolio, making the stock its 10th largest position. Exome Asset Management LLC's holdings in Intuitive Surgical were worth $3,149,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Chilton Capital Management LLC increased its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares during the period. Global Financial Private Client LLC increased its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the period. Elite Financial Inc. acquired a new stake in Intuitive Surgical during the 1st quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical during the 1st quarter valued at approximately $30,000. Finally, TD Capital Management LLC increased its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent analyst reports. UBS Group increased their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a research report on Wednesday, July 23rd. Piper Sandler reissued an "overweight" rating and set a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. BTIG Research increased their target price on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Finally, Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Insiders Place Their Bets

In other news, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares of the company's stock, valued at $9,368,059.23. This represents a 59.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 over the last ninety days. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded down $6.17 during trading hours on Friday, hitting $449.68. 2,218,377 shares of the company's stock traded hands, compared to its average volume of 2,025,311. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The stock has a market capitalization of $161.20 billion, a price-to-earnings ratio of 62.72, a PEG ratio of 4.72 and a beta of 1.61. The company has a fifty day simple moving average of $487.55 and a 200-day simple moving average of $509.57.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the firm posted $1.78 EPS. The business's revenue was up 21.4% compared to the same quarter last year. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.